These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8878598)

  • 1. Recovery of active beta-lactamases from Proteus vulgaris and RTEM-1 hybrid by random mutagenesis by using a dnaQ strain of Escherichia coli.
    Hosseini-Mazinani SM; Nakajima E; Ihara Y; Kameyama KZ; Sugimoto K
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2152-9. PubMed ID: 8878598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of serine 237 in class A beta-lactamase of Proteus vulgaris modifies its unique substrate specificity.
    Tamaki M; Nukaga M; Sawai T
    Biochemistry; 1994 Aug; 33(33):10200-6. PubMed ID: 8060986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and expression of the gene(s) for chromosome-mediated beta-lactamase production of Proteus vulgaris in Escherichia coli.
    Maejima T; Ohya Y; Mitsuhashi S; Inoue M
    Plasmid; 1987 Sep; 18(2):120-6. PubMed ID: 2829250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems related to determination of MICs of oximino-type expanded-spectrum cephems for Proteus vulgaris.
    Ohno A; Ishii Y; Ma L; Yamaguchi K
    J Clin Microbiol; 2000 Feb; 38(2):677-81. PubMed ID: 10655366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.
    Madec S; Blin C; Krishnamoorthy R; Picard B; Chaibi el B; Fouchereau-Péron M; Labia R
    FEMS Microbiol Lett; 2002 May; 211(1):13-6. PubMed ID: 12052544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomally encoded cephalosporin-hydrolyzing beta-lactamase of Proteus vulgaris RO104 belongs to Ambler's class A.
    Péduzzi J; Reynaud A; Baron P; Barthélémy M; Labia R
    Biochim Biophys Acta; 1994 Jul; 1207(1):31-9. PubMed ID: 8043607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common system controls the induction of very different genes. The class-A beta-lactamase of Proteus vulgaris and the enterobacterial class-C beta-lactamase.
    Datz M; Joris B; Azab EA; Galleni M; Van Beeumen J; Frère JM; Martin HH
    Eur J Biochem; 1994 Nov; 226(1):149-57. PubMed ID: 7957242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
    Sirot D; Chanal C; Henquell C; Labia R; Sirot J; Cluzel R
    J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of mutant SHV-5 beta-lactamases constructed by substitution of isoleucine or valine for methionine at position 69.
    Giakkoupi P; Miriagou V; Gazouli M; Tzelepi E; Legakis NJ; Tzouvelekis LS
    Antimicrob Agents Chemother; 1998 May; 42(5):1281-3. PubMed ID: 9593168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.
    Palzkill T; Le QQ; Venkatachalam KV; LaRocco M; Ocera H
    Mol Microbiol; 1994 Apr; 12(2):217-29. PubMed ID: 8057847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-saturation studies of beta-lactamase: production and characterization of mutant beta-lactamases with all possible amino acid substitutions at residue 71.
    Schultz SC; Richards JH
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1588-92. PubMed ID: 3513181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid sequence determinants of beta-lactamase structure and activity.
    Huang W; Petrosino J; Hirsch M; Shenkin PS; Palzkill T
    J Mol Biol; 1996 May; 258(4):688-703. PubMed ID: 8637002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis.
    Pérez A; Pérez-Llarena FJ; García P; Kerff F; Beceiro A; Galleni M; Bou G
    J Antimicrob Chemother; 2014 Sep; 69(9):2407-11. PubMed ID: 24845871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residues Distal to the Active Site Contribute to Enhanced Catalytic Activity of Variant and Hybrid β-Lactamases Derived from CTX-M-14 and CTX-M-15.
    He D; Chiou J; Zeng Z; Liu L; Chen X; Zeng L; Chan EW; Liu JH; Chen S
    Antimicrob Agents Chemother; 2015 Oct; 59(10):5976-83. PubMed ID: 26169409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altering enzymatic activity: recruitment of carboxypeptidase activity into an RTEM beta-lactamase/penicillin-binding protein 5 chimera.
    Chang YH; Labgold MR; Richards JH
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2823-7. PubMed ID: 2181451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases.
    Randegger CC; Hächler H
    J Antimicrob Chemother; 2001 May; 47(5):547-54. PubMed ID: 11328764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases.
    Caniça MM; Barthélémy M; Gilly L; Labia R; Krishnamoorthy R; Paul G
    Antimicrob Agents Chemother; 1997 Feb; 41(2):374-8. PubMed ID: 9021194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.